Portola Capital Partners
VC
INVESTOR TYPE
Active
STATUS
2
PROFESSIONALS
2
INVESTMENTS
2
EXITS
Description
Portola Capital Partners is a healthcare investment and advisory firm that focuses on innovation, growth and cross-border deals in North America, Asia, Europe and emerging markets. The firm also focuses on investing in emerging public and private biotechnology and device companies.
Website
Investor Status
Actively Seeking New Investments
Year Founded
2010
Primary Investor Type
Venture Capital
Primary Office
- 450 Lexington Avenue
- Suite 39B
- New York, NY 10017
- United States
Portola Capital Partners Investments (2)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Aptinyx | 15-Sep-2015 | Seed Round | Drug Discovery | Generating Revenue | ||
| 000000 | 02-Dec-2014 | 00000 00000 | 0000 | Drug Discovery | Clinical Trials - Phase 3 |
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Portola Capital Partners’s full profile, request a free trial.
Portola Capital Partners Exits (2)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Aptinyx | 21-Jun-2018 | IPO | 00000 | Completed |
|
| 000000 | 28-Aug-2015 | 000000000000000000 | 00.000 | Completed |
|
Portola Capital Partners Team (2)
| Name | Title | Deals | Funds | Boards | Office | Contact Info |
|---|---|---|---|---|---|---|
| Greg Spalasso | Executive | New York, NY | ||||
| Sasha Blaug Ph.D | Senior Investment Analyst & Vice President | New York, NY |
Portola Capital Partners Co-Investors (17)
| Name | With | Exits | Lead Partner |
|---|---|---|---|
| Adams Street Partners | 2 | 0 | 0 |
| Lundbeck | 0 | 0 | |
| Northwestern University Endowment | 0 | 0 | |
| PathoCapital | 0 | 0 | 0 |
| Sabby Management | 0 | 0 |